Clinical Trial Update: Assessment of Hyperphosphorylated Tau PET Binding in Primary Progressive Aphasia and Frontotemporal Dementia [Phase 1]

View source ↗

Summary

A Phase 1 Mayo Clinic study evaluated hyperphosphorylated tau PET binding in primary progressive aphasia and behavioral variant frontotemporal dementia; results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Behavioral Variant Frontotemporal Dementia
• Progressive Aphasia

Snippet

Sponsor: Mayo Clinic | Conditions: Primary Progressive Aphasia, Behavioral Variant of Frontotemporal Dementia | Phase 1 | Status: COMPLETED | Results posted: 2025-11-21